Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Cancer Resectable × Antineoplastic Agents × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Pancreatic Cancer Resectable 1 Ovarian Carcinosarcoma 1 Noonan Syndrome 5 1 Neoplasms 1 Liver Neoplasms 1 Immune-related Adverse Event 1 Esophageal Neoplasms 1 Early Hormone Receptor-positive Breast Cancer 1 Breast Neoplasms 1 Advanced Solid Tumor 1

Interventions

nimotuzumab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06368063 2024-05-08

The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer

Xi'an Jiaotong University

Phase 4 Recruiting

Gastrointestinal

Pancreatic Cancer Resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡